ijms-logo

Journal Browser

Journal Browser

Molecular and Translational Research on Bone Tumors 2.0

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: 20 May 2024 | Viewed by 5001

Special Issue Editors


E-Mail Website
Guest Editor
Bone Physiopathology Research Unit, Genetics and Rare Diseases Research Division, Bambino Gesù Children’s Hospital, IRCCS Viale San Paolo, 1500146 Rome, Italy
Interests: bone cell biology; bone diseases; osteoclasts; osteoblasts; osteocytes; bone metabolism
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Bone Physiopathology Group, Multifactorial Disease and Complex Phenotype Research Area, Bambino Gesù Children’s Hospital, 00146 Rome, Italy
Interests: bone cell biology; bone diseases; bone regeneration; mesenchymal stem cells; osteoclasts; osteoblasts; osteocytes; extracellular vesicles
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Bone tumours can affect every part of the skeleton and can develop in any part of the bone, from the centre to the surface. Their growth can destroy healthy tissue and reduce bone strength, causing pathologic fractures. Primary bone tumours and metastases are characterized by the perturbation of physiological bone remodelling activity by osteoblasts and osteoclasts. The crosstalk between cancer and bone cells allows the growth and the spread of the tumour.

Due to the unknown aetiology, complexity and heterogeneity of most bone tumours, a better understanding of the mechanisms underlying the oncogenesis is still necessary.

This Special Issue will focus both on benign and malignant bone tumours, in particular on:

  • The analysis of the molecular and cellular mechanisms leading to the onset of these tumours;
  • The identification of new therapeutic approaches;
  • The detection of biomarkers for early diagnosis.

Both original research and review articles are welcome.

Dr. Michela Rossi
Dr. Andrea Del Fattore
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • primary bone tumours
  • metastatic bone tumour
  • therapy
  • biomarkers
  • epigenetic factors
  • immune-oncology

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

18 pages, 1441 KiB  
Review
Aplastic Anemia as a Roadmap for Bone Marrow Failure: An Overview and a Clinical Workflow
by Antonio G. Solimando, Carmen Palumbo, Mary Victoria Pragnell, Max Bittrich, Antonella Argentiero and Markus Krebs
Int. J. Mol. Sci. 2022, 23(19), 11765; https://doi.org/10.3390/ijms231911765 - 04 Oct 2022
Cited by 6 | Viewed by 4373
Abstract
In recent years, it has become increasingly apparent that bone marrow (BM) failures and myeloid malignancy predisposition syndromes are characterized by a wide phenotypic spectrum and that these diseases must be considered in the differential diagnosis of children and adults with unexplained hematopoiesis [...] Read more.
In recent years, it has become increasingly apparent that bone marrow (BM) failures and myeloid malignancy predisposition syndromes are characterized by a wide phenotypic spectrum and that these diseases must be considered in the differential diagnosis of children and adults with unexplained hematopoiesis defects. Clinically, hypocellular BM failure still represents a challenge in pathobiology-guided treatment. There are three fundamental topics that emerged from our review of the existing data. An exogenous stressor, an immune defect, and a constitutional genetic defect fuel a vicious cycle of hematopoietic stem cells, immune niches, and stroma compartments. A wide phenotypic spectrum exists for inherited and acquired BM failures and predispositions to myeloid malignancies. In order to effectively manage patients, it is crucial to establish the right diagnosis. New theragnostic windows can be revealed by exploring BM failure pathomechanisms. Full article
(This article belongs to the Special Issue Molecular and Translational Research on Bone Tumors 2.0)
Show Figures

Figure 1

Back to TopTop